KR920703560A - 시스-β-페닐글리시딘-(2R,3R)산의 제조방법 - Google Patents

시스-β-페닐글리시딘-(2R,3R)산의 제조방법

Info

Publication number
KR920703560A
KR920703560A KR1019920701997A KR920701997A KR920703560A KR 920703560 A KR920703560 A KR 920703560A KR 1019920701997 A KR1019920701997 A KR 1019920701997A KR 920701997 A KR920701997 A KR 920701997A KR 920703560 A KR920703560 A KR 920703560A
Authority
KR
South Korea
Prior art keywords
methylbenzylamine
acid
salt
cis
mixture
Prior art date
Application number
KR1019920701997A
Other languages
English (en)
Other versions
KR100190559B1 (en
Inventor
뒤쉐느 장-삐에르
뮬호제 미쉘
Original Assignee
필라드 자끄
로오느-푸우랜크 로레르 소시에테 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 필라드 자끄, 로오느-푸우랜크 로레르 소시에테 아노님 filed Critical 필라드 자끄
Publication of KR920703560A publication Critical patent/KR920703560A/ko
Application granted granted Critical
Publication of KR100190559B1 publication Critical patent/KR100190559B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Photoreceptors In Electrophotography (AREA)

Abstract

내용 없음

Description

시스-β-페닐글리시딘-(2R, 3R)산의 제조방법
[도면의 간단한 설명]
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. (R) (+) -α-메틸벤질아민과 (2R, 3R) -β-페닐글리시딘산, (2S, 3S)-β-페닐글리시딘산, (2R, 3S)-β-페닐글리시딘산 및 (2S,3R)-β-페니리글리시딘산의 염의 혼합물 용액중,(2R3R)-β-페닐 글리시딘산과 (R)(+)-α-메틸벤질아민염을 적합한 용매 내에서 선택적으로 결정화하고, 얻어진 생성물을 분리하고, 임의로 알칼리 금속염 또는 에스테르로 전환시킴을 특징으로 하는, 임의로 염 또는 에스테르 형태의 하기 일반식의 (2R,3R)-시스-β-페닐글리시딘산의 제조방법:
  2. 제1항에 있어서, 용매는 물 및 임의로 물과 혼합된 C1-C4를 함유하는 지방족 알콜, 에테르 및 케톤으로 부터 선택된 유기 용매로 부터 선택됨을 특징으로 하는 방법.
  3. 제1 및 제2항 중 어느 한항에 있어서, 아세톤이 제1항에 정의된 염의 혼합물의 수성, 유기 또는 히드로유기용액에 첨가되고나서, (2R, 3R)-β-페닐글리시딘산과 (R)(+)-α-메틸벤질아민의 염이 침전되고, 여과로 분리됨을 특징으로 하는 방법.
  4. 제1항 내지 제3항중 어느 한 항에 있어서, β-페닐 글리시딘산의 시스 이성질체와 (R) (+)-α-메틸벤질아민의 염이 대략 80% 및 β-페닐글리시딘산의 트란스 이성질체와 (R) (+)-α-메틸벤질아민의 염 대략 20%로 구성된 혼합물이 적용됨을 특징으로 하는 방법.
  5. 제1항 내지 제4항중 어느 한항에 있어서, (R)(+)-α-메틸벤질아민과 β-페닐글리시딘산의 시스 및 트란스 이성질체의 혼합물은, 현장에서 제조된 β-페닐글리시딘산의 시스 및 트란스 이성질체의 혼합물 상의 (+)-α-메틸벤질아민의 작용에 의해 얻어짐을 특징으로 하는 방법.
  6. 제1항 내지 제4항 중 어느 한 항에 있어서, (R)(+)-α-메틸벤질아민과 β-페닐글리시딘산의 시스 및 트란스 이성질체의 혼합물은, 현장에서 임의로 제조된 시스 및 트란스 β-페닐글리시딘산의 알칼리 금속염 혼합물 상의 (+)-α-메틸벤질 아민염의 작용에 의해 얻어짐을 특징으로 하는 방법.
  7. 하기 일반식:
    (식에서, R은 수소원자 또는 아세틸 라디칼을 지시하고, R1은 페닐 또는 t-부톡시 라디칼을 지시한다)의 탁산 유도체의, 공지된 방법에 따른, 제조를 위한 제1항 내지 제6항중 어느 한 항의 방법에 따라 얻어진 생성물의 이용.
  8. 제1항의 방법에 따라 얻어진 생성물을 사용한 방법에 의해 얻어지는 하기 일반식의 생성물:
    식에서 R은 수소원자 또는 아세틸 라디칼을 지시하고, R1은 페닐 또는 t-부톡시 라디칼을 지시한다.
  9. 불활성 또는 생리학적으로 활성인 하나 또는 다수의 제약학적으로 허용가능한 생성물과 조합하여 제8항에 따른 생성물을 함유함을 특징으로 하는 제약학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920701997A 1990-02-21 1992-08-20 Method for preparing cis--g(b)-phenylglycidic-(2r,3r) acid KR100190559B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR90/02098 1990-02-21
FR9002098A FR2658513B1 (fr) 1990-02-21 1990-02-21 Procede de preparation de l'acide cis-beta-phenylglycidique-(2r,3r).
PCT/FR1991/000133 WO1991013066A2 (fr) 1990-02-21 1991-02-20 PROCEDE DE PREPARATION DE L'ACIDE CIS-β-PHENYLGLYCIDIQUE-(2R,3R)

Publications (2)

Publication Number Publication Date
KR920703560A true KR920703560A (ko) 1992-12-18
KR100190559B1 KR100190559B1 (en) 1999-06-01

Family

ID=9393961

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920701997A KR100190559B1 (en) 1990-02-21 1992-08-20 Method for preparing cis--g(b)-phenylglycidic-(2r,3r) acid

Country Status (24)

Country Link
US (1) US5256803A (ko)
EP (1) EP0515541B1 (ko)
JP (1) JP3012325B2 (ko)
KR (1) KR100190559B1 (ko)
AT (1) ATE104970T1 (ko)
AU (1) AU647088B2 (ko)
CA (1) CA2071979C (ko)
CZ (1) CZ279594B6 (ko)
DE (1) DE69101836T2 (ko)
DK (1) DK0515541T3 (ko)
ES (1) ES2063499T3 (ko)
FI (1) FI113766B (ko)
FR (1) FR2658513B1 (ko)
HU (1) HU207856B (ko)
IE (1) IE65338B1 (ko)
IL (1) IL97276A (ko)
NO (1) NO179836C (ko)
NZ (1) NZ237173A (ko)
PT (1) PT96848B (ko)
RU (1) RU2056414C1 (ko)
SK (1) SK278331B6 (ko)
WO (1) WO1991013066A2 (ko)
YU (1) YU48670B (ko)
ZA (1) ZA911280B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3140093A (en) * 1991-11-22 1993-06-15 University Of Mississippi, The Synthesis and optical resolution of the taxol side chain and related compounds
JPH07505887A (ja) * 1992-04-17 1995-06-29 アボツト・ラボラトリーズ タキソール誘導体
FR2691460B1 (fr) * 1992-05-21 1994-07-22 Rhone Poulenc Rorer Sa Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent.
IL107950A (en) 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
US5646176A (en) 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
CA2155304C (en) * 1993-02-05 2010-07-20 Charles Swindell Syntheses of paclitaxel, analogs and intermediates with variable a-ring side chains
US5684175A (en) * 1993-02-05 1997-11-04 Napro Biotherapeutics, Inc. C-2' hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- 3-phenylisoserine and production process therefor
ATE264316T1 (de) * 1993-06-11 2004-04-15 Upjohn Co Delta 6,7-taxol derivate antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen
IL127598A (en) * 1994-01-28 2003-04-10 Upjohn Co Process for preparing isotaxol analogs
CA2216866A1 (en) * 1995-04-20 1996-10-24 Stanley Michael Roberts Asymmetric epoxides, their synthesis and use
US5675025A (en) * 1995-06-07 1997-10-07 Napro Biotherapeutics, Inc. Paclitaxel synthesis from precursor compounds and methods of producing the same
FR2740451B1 (fr) * 1995-10-27 1998-01-16 Seripharm Nouveaux intermediaires pour l'hemisynthese de taxanes, leurs procedes de preparation et leur utilisation dans la synthese generale des taxanes
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis
US6228955B1 (en) 1996-04-19 2001-05-08 Chirotech Technology, Ltd. Asymmetric epoxides, their synthesis and use
US5750737A (en) * 1996-09-25 1998-05-12 Sisti; Nicholas J. Method for paclitaxel synthesis
FR2776292B1 (fr) * 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
US6479679B1 (en) 2001-04-25 2002-11-12 Napro Biotherapeutics, Inc. Two-step conversion of protected taxane ester to paclitaxel
US6452025B1 (en) 2001-04-25 2002-09-17 Napro Biotherapeutics, Inc. Three-step conversion of protected taxane ester to paclitaxel

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901915A (en) * 1973-10-10 1975-08-26 Hoffmann La Roche Optical resolution of organic carboxylic acids
JPS56110683A (en) * 1980-02-07 1981-09-01 Taisho Pharmaceut Co Ltd Preparation of optical active epoxysuccinate
JPS6013775A (ja) * 1983-07-05 1985-01-24 Sawai Seiyaku Kk 光学活性３−（ｐ−アルコキシフエニル）グリシツド酸アルカリ金属塩の製造法
JPS61145174A (ja) * 1984-12-20 1986-07-02 Nippon Chemiphar Co Ltd 新規な光学活性エポキシプロピオン酸エステル誘導体の製造法
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601676B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
JPH01226881A (ja) * 1988-03-04 1989-09-11 Tanabe Seiyaku Co Ltd 光学活性３−フェニルグリシッド酸エステル類化合物の製法
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
US4885375A (en) * 1988-05-18 1989-12-05 Marion Laboratories, Inc. Resolution of 3-(4-methoxyphenyl)glycidic acid with in situ conversion to alkyl esters
DE3906953A1 (de) * 1989-03-04 1990-09-20 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung optisch reiner oxirancarbonsaeuren
CA2023645C (fr) * 1989-08-23 2002-03-26 Jean-Noel Denis Procede pour la preparation enantioselective de derives de la phenylisoserine
IT1240651B (it) * 1990-05-17 1993-12-17 Zambon Spa Processo per la risoluzione di derivati glicidici
DE69113048T2 (de) * 1990-08-01 1996-02-22 Smithkline Beecham Corp Verfahren und zwischenprodukte für die herstellung von 2-hydroxy-3-sulfido-3-phenylpropansäuren.

Also Published As

Publication number Publication date
CS9100439A2 (en) 1991-09-15
WO1991013066A2 (fr) 1991-09-05
AU647088B2 (en) 1994-03-17
FR2658513A1 (fr) 1991-08-23
ES2063499T3 (es) 1995-01-01
ATE104970T1 (de) 1994-05-15
IE65338B1 (en) 1995-10-18
IL97276A (en) 1995-03-30
NO179836B (no) 1996-09-16
DE69101836D1 (de) 1994-06-01
EP0515541B1 (fr) 1994-04-27
EP0515541A1 (fr) 1992-12-02
DE69101836T2 (de) 1994-08-18
HU9202668D0 (en) 1992-12-28
FR2658513B1 (fr) 1994-02-04
AU7346191A (en) 1991-09-18
PT96848B (pt) 1998-07-31
HU207856B (en) 1993-06-28
CA2071979C (fr) 2002-10-29
NZ237173A (en) 1993-07-27
YU30291A (sh) 1993-11-16
PT96848A (pt) 1991-10-31
CZ279594B6 (cs) 1995-05-17
FI113766B (fi) 2004-06-15
JP3012325B2 (ja) 2000-02-21
NO923225L (no) 1992-08-18
ZA911280B (en) 1991-12-24
IL97276A0 (en) 1992-05-25
US5256803A (en) 1993-10-26
YU48670B (sh) 1999-06-15
KR100190559B1 (en) 1999-06-01
FI923680A (fi) 1992-08-17
DK0515541T3 (da) 1994-06-13
IE910587A1 (en) 1991-08-28
RU2056414C1 (ru) 1996-03-20
NO923225D0 (no) 1992-08-18
JPH05503534A (ja) 1993-06-10
CA2071979A1 (fr) 1991-08-22
SK278331B6 (en) 1996-11-06
FI923680A0 (fi) 1992-08-17
NO179836C (no) 1996-12-27
WO1991013066A3 (fr) 1991-10-17

Similar Documents

Publication Publication Date Title
KR920703560A (ko) 시스-β-페닐글리시딘-(2R,3R)산의 제조방법
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
KR910019999A (ko) 치환된 1,3-벤조디옥솔 화합물, 이들의 생성방법, 이들로 구성된 제약학적 조성물 및 이들을 사용한 치료방법
KR920012035A (ko) 치환된 피리딜-디하이드록시-헵텐 산 및 그의 염
SU664529A3 (ru) Инсектицидна композици
KR930019597A (ko) 탁산 유도체, 그의 제조방법 및 종양에 있어서의 용도
GB1394542A (en) Optically active isomers of hydroxyamines
KR950704253A (ko) 5-HT₁-유사 작용제로서의 카바졸 유도체의 거울상이성질체(Enantiomers of Carbazole Derivatives as 5-HT₁-Like Agonists)
RU96120366A (ru) Способ получения энантиомерно чистых соединений имидазолила, энантиомерно чистая кислая аддитивная соль имидазолила и в-пироглутаминовой кислоты
KR930016436A (ko) 4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물
JP4015696B2 (ja) レボブピバカインと同類のピペリジンカルボキサニリド麻酔剤の製造に用いるラセミ化法
KR927003561A (ko) β-페닐이소세린의 유도체, 그의 제조 및 이용
DE69300453T2 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
FR2491761A1 (fr) Derives de l'adenosine a activite anti-inflammatoire et analgesique et compositions therapeutiques qui les contiennent en tant que principe actif
BR8105437A (pt) Processo para a preparacao de derivados de azolilaquila, composicoes fungicidas, processos para combater fungos e para a preparacao das composicoes
KR880005079A (ko) 3-아미노카르보닐-1,4-디히드로피리딘-5-카르복실산 화합물, 그의 제조방법, 및 그를 함유하는 약학조성물
CA1140155A (fr) PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU 1.alpha.,25-DIHYDROXY CHOLECALCIFEROL
RU95102479A (ru) Аналоги 15-дезоксиспергуалина, способ их получения и фармкомпозиция на их основе
CH625799A5 (ko)
KR880011096A (ko) 광학 활성 옥소-이소인돌리닐 유도체
FR2656865A1 (fr) Compose non ionique iode, son procede de preparation et produit de contraste le contenant.
DE1793693B2 (ko)
FR2520618A1 (fr) Application therapeutique de certains derives de la (trimethoxy-3,4,5) cinnamoyl-1 piperazine et de leurs sels d'acide
EP0030505B1 (fr) Nouvelles lactones substituées par un reste d'acide aminé, leur préparation et leur application au dédoublement de ces lactones et de ces acides aminés
DE10150063C2 (de) Verfahren zur mehrstufigen Herstellung von alpha-Liponsäure, neue 1,3-Dithiane und deren Verwendung

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20101222

Year of fee payment: 13

EXPY Expiration of term